المؤلفون: Alexander F. Markham, Constanze Bonifer, Olusola O. Faluyi, P. Louise Coletta, Mark A. Hull

المصدر: Oncology Letters

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Adenoma, myelomonocytic, Adenomatous polyposis coli, Population, Spleen, medicine.disease_cause, mouse lysozyme, 03 medical and health sciences, 0302 clinical medicine, medicine, education, intestine, education.field_of_study, biology, ApcMin/+ mouse, Melanoma, Cancer, Articles, Cell cycle, medicine.disease, digestive system diseases, Apc, tumorigenesis, 030104 developmental biology, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecfed1841243dbcd9b50520611c163a3
http://europepmc.org/articles/PMC7884874

المؤلفون: Sarah E. M. Howie, Olusola O Faluyi, Paul M. Fitch

المصدر: Faluyi, O O, Fitch, P & Howie, S 2017, ' An increased CD25-positive intestinal regulatory T-lymphocyte population is dependent on Cox-2 activity in the Apc Min/+ model ', Clinical & Experimental Immunology . https://doi.org/10.1111/cei.13055

مصطلحات موضوعية: 0301 basic medicine, Genes, APC, Regulatory T cell, Immunology, Population, chemical and pharmacologic phenomena, Biology, medicine.disease_cause, T-Lymphocytes, Regulatory, Mucosal-Associated Invariant T Cells, Familial adenomatous polyposis, Immunophenotyping, 03 medical and health sciences, Paracrine signalling, Mice, Immune system, Thymic Stromal Lymphopoietin, Transforming Growth Factor beta, medicine, Immunology and Allergy, Animals, IL-2 receptor, Intestinal Mucosa, education, Mice, Knockout, education.field_of_study, Interleukin-2 Receptor alpha Subunit, FOXP3, Forkhead Transcription Factors, hemic and immune systems, Original Articles, medicine.disease, Immunohistochemistry, Disease Models, Animal, 030104 developmental biology, medicine.anatomical_structure, Cell Transformation, Neoplastic, Cyclooxygenase 2, Cytokines, Carcinogenesis, Colorectal Neoplasms, Biomarkers

وصف الملف: application/msword

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::724d9335fd668c9a022f0ba5f3a95fae
https://hdl.handle.net/20.500.11820/733f9c7a-2477-453a-91e4-d9b03ba03cb2

المؤلفون: Natasha B. Leighl, Olusola O Faluyi

المصدر: Lung Cancer Management. 1:7-10

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Chemotherapy, Angiostatin, Bevacizumab, biology, Angiogenesis, business.industry, medicine.medical_treatment, medicine.disease, Oncology, Tolerability, medicine, biology.protein, Cancer research, Endostatin, Lung cancer, business, Platelet-derived growth factor receptor, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c33bc5b0d310635187177d03545aae69
https://doi.org/10.2217/lmt.12.2

المؤلفون: Olusola O, Faluyi, Charlie, Gourley, John F, Smyth, Dana, Faratian, Alistair R, Williams, Tzyvia, Rye, Ron, Rye, Moira, Stewart, Melanie J, Mackean

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 20(9)

مصطلحات موضوعية: Ovarian Neoplasms, Risk, Time Factors, Brain Neoplasms, Incidence, Carcinoma, Breast Neoplasms, Neoplasms, Second Primary, Carcinoma, Ovarian Epithelial, Middle Aged, Cohort Studies, Recurrence, Humans, Female, Neoplasms, Glandular and Epithelial, Aged

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::9fb645739f1d624b9f8e2a613cc0e285
https://pubmed.ncbi.nlm.nih.gov/21370594

المؤلفون: Gray S; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Rd., Manchester M20 4BX, UK.; Department of Molecular and Clinical Cancer Medicine, Faculty of Health and Life Sciences, University of Liverpool, Ashton St., Liverpool L69 3GB, UK.; Department of Medical Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Pembroke Pl, Liverpool L7 8YA, UK., Letissier O; Centre Eugène Marquis, Av. De la Bataille Flandres Dunkerque-CS 44229, CEDEX, 35042 Rennes, France., d'Abrigeon C; Centre Eugène Marquis, Av. De la Bataille Flandres Dunkerque-CS 44229, CEDEX, 35042 Rennes, France., Shah D; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Rd., Manchester M20 4BX, UK., Wardell S; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Rd., Manchester M20 4BX, UK., Faluyi O; Department of Medical Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Pembroke Pl, Liverpool L7 8YA, UK., Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Rd., Manchester M20 4BX, UK.; Department of Oncology, Oncohealth Institute, Jimémez Díaz University Hospital, Av. de los Reyes Catolicos 2, 28040 Madrid, Spain.; Division of Cancer Sciences, University of Manchester, Oxford Rd., Manchester M13 9PL, UK., Hubner RA; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Rd., Manchester M20 4BX, UK.; Division of Cancer Sciences, University of Manchester, Oxford Rd., Manchester M13 9PL, UK., Edeline J; Centre Eugène Marquis, Av. De la Bataille Flandres Dunkerque-CS 44229, CEDEX, 35042 Rennes, France., Valle JW; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Rd., Manchester M20 4BX, UK.; Division of Cancer Sciences, University of Manchester, Oxford Rd., Manchester M13 9PL, UK., McNamara MG; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Rd., Manchester M20 4BX, UK.; Division of Cancer Sciences, University of Manchester, Oxford Rd., Manchester M13 9PL, UK.

المصدر: Cancers [Cancers (Basel)] 2023 Jun 03; Vol. 15 (11). Date of Electronic Publication: 2023 Jun 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: McNamara MG; Division of Cancer Sciences, University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Swain J; Leeds Cancer Research UK Clinical Trials Unit, University of Leeds, Leeds, UK., Craig Z; Leeds Cancer Research UK Clinical Trials Unit, University of Leeds, Leeds, UK., Sharma R; Imperial College, London, UK., Faluyi O; Clatterbridge Cancer Centre, Liverpool, UK., Wadsley J; Weston Park Hospital, Sheffield, UK., Morgan C; Velindre Cancer Centre, Cardiff, UK., Wall LR; Western General Hospital, Edinburgh, UK., Chau I; The Royal Marsden NHS Foundation Trust, London, UK., Reed N; Beatson Oncology Centre, Glasgow, UK., Sarker D; King's College Hospital, London, UK., Margetts J; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Krell D; Royal Free London, London, UK., Cave J; Southampton University Hospitals NHS Trust, Southampton, UK., Sothi S; University Hospital Coventry, Coventry, UK., Anthoney A; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Bell C; The Christie NHS Foundation Trust, Manchester, UK., Patel A; The Christie NHS Foundation Trust, Manchester, UK., Oughton JB; Leeds Cancer Research UK Clinical Trials Unit, University of Leeds, Leeds, UK., Cairns DA; Leeds Cancer Research UK Clinical Trials Unit, University of Leeds, Leeds, UK., Mansoor W; The Christie NHS Foundation Trust, Manchester, UK., Lamarca A; Division of Cancer Sciences, University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Hubner RA; Division of Cancer Sciences, University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Valle JW; Division of Cancer Sciences, University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.

المصدر: EClinicalMedicine [EClinicalMedicine] 2023 Jun 02; Vol. 60, pp. 102015. Date of Electronic Publication: 2023 Jun 02 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

المؤلفون: McNamara MG; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Bridgewater J; University College London, London, United Kingdom., Palmer DH; Clatterbridge Cancer Centre and Liverpool Experimental Cancer Medicine Centre, Liverpool, United Kingdom., Faluyi O; Clatterbridge Cancer Centre and Liverpool Experimental Cancer Medicine Centre, Liverpool, United Kingdom., Wasan H; Imperial College London, London, United Kingdom., Patel A; Department of Pharmacy, The Christie NHS Foundation Trust, Manchester, United Kingdom., Ryder WD; Manchester Clinical Trials Unit, University of Manchester, Manchester, United Kingdom., Barber S; Manchester Clinical Trials Unit, University of Manchester, Manchester, United Kingdom., Gnanaranjan C; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Ghazaly E; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Beatson West of Scotland Cancer Centre, University of Glasgow, United Kingdom., Evans TRJ; Beatson West of Scotland Cancer Centre, University of Glasgow, United Kingdom., Valle JW; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.

المصدر: The oncologist [Oncologist] 2021 Apr; Vol. 26 (4), pp. e669-e678. Date of Electronic Publication: 2020 Dec 03.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Bile Duct Neoplasms*/drug therapy , Biliary Tract Neoplasms*/drug therapy, Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bile Ducts, Intrahepatic ; Cisplatin/therapeutic use ; Cytidine Monophosphate/analogs & derivatives ; Disease-Free Survival ; Humans ; Male ; Middle Aged ; Treatment Outcome

المؤلفون: Palmer DH; Liverpool Experimental Cancer Medicine Centre, Liverpool, UK. palmerd@liverpool.ac.uk.; The Clatterbridge Cancer Centre, Bebington, Wirral, UK. palmerd@liverpool.ac.uk., Valle JW; Division of Cancer Sciences, University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Ma YT; Queen Elizabeth Hospital, Birmingham, UK.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Faluyi O; The Clatterbridge Cancer Centre, Bebington, Wirral, UK., Neoptolemos JP; Liverpool Experimental Cancer Medicine Centre, Liverpool, UK., Jensen Gjertsen T; Targovax ASA, Oslo, Norway., Iversen B; Targovax ASA, Oslo, Norway., Amund Eriksen J; Targovax ASA, Oslo, Norway., Møller AS; Targovax ASA, Oslo, Norway., Aksnes AK; Targovax ASA, Oslo, Norway., Miller R; Targovax ASA, Oslo, Norway., Dueland S; The Norwegian Radium Hospital and Oslo University Hospital, Oslo, Norway.

المصدر: British journal of cancer [Br J Cancer] 2020 Mar; Vol. 122 (7), pp. 971-977. Date of Electronic Publication: 2020 Feb 17.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Deoxycytidine/*analogs & derivatives , Granulocyte-Macrophage Colony-Stimulating Factor/*therapeutic use , Pancreatic Neoplasms/*drug therapy, Adenocarcinoma/pathology ; Aged ; Deoxycytidine/pharmacology ; Deoxycytidine/therapeutic use ; Female ; Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology ; Humans ; Male ; Middle Aged ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/surgery ; Gemcitabine

المؤلفون: Craig Z; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, West Yorkshire, UK., Swain J; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, West Yorkshire, UK., Batman E; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, West Yorkshire, UK., Wadsley J; Department of Oncology, Weston Park Hospital, Sheffield, Sheffield, UK., Reed N; Beatson West of Scotland Cancer Centre, Glasgow, Glasgow, UK., Faluyi O; Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, UK., Cave J; Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, Southampton, UK., Sharma R; Department of Surgery and Cancer, Imperial College London, London, London, UK., Chau I; Gastrointestinal and Lymphoma Unit, Royal Marsden Hospital NHS Trust, London, London, UK., Wall L; Department of Oncology, Western General Hospital, Edinburgh, UK., Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Hubner R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Mansoor W; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Sarker D; Comprehensive Cancer Centre, King's College Hospital, London, UK., Meyer T; Department of Oncology, University College London Cancer Institute, London, UK., Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, West Yorkshire, UK., Howard H; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, West Yorkshire, UK., Valle JW; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, The University of Manchester, Manchester, UK., McNamara MG; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK Mairead.McNamara@christie.nhs.uk.; Division of Cancer Sciences, The University of Manchester, Manchester, UK.

المصدر: BMJ open [BMJ Open] 2020 Feb 05; Vol. 10 (2), pp. e034527. Date of Electronic Publication: 2020 Feb 05.

نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Neuroendocrine*/drug therapy, Docetaxel/*therapeutic use , Fluorouracil/*therapeutic use , Irinotecan/*therapeutic use , Leucovorin/*therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Clinical Trials, Phase II as Topic ; Humans ; Multicenter Studies as Topic ; Quality of Life ; Randomized Controlled Trials as Topic

المؤلفون: Jones RP; The Royal Liverpool University Hospital, Liverpool, England., Psarelli EE; University of Liverpool, Liverpool, England., Jackson R; University of Liverpool, Liverpool, England., Ghaneh P; The Royal Liverpool University Hospital, Liverpool, England.; University of Liverpool, Liverpool, England., Halloran CM; The Royal Liverpool University Hospital, Liverpool, England.; University of Liverpool, Liverpool, England., Palmer DH; University of Liverpool, Liverpool, England.; The Clatterbridge Cancer Centre, Wirral, England., Campbell F; The Royal Liverpool University Hospital, Liverpool, England., Valle JW; University of Manchester/The Christie, Manchester, England., Faluyi O; The Clatterbridge Cancer Centre, Wirral, England., O'Reilly DA; Manchester University Foundation Trust, Manchester, England., Cunningham D; Royal Marsden Hospital, London, England., Wadsley J; Weston Park Hospital, Sheffield, England., Darby S; Weston Park Hospital, Sheffield, England., Meyer T; Royal Free Hospital, London, England., Gillmore R; Royal Free Hospital, London, England., Anthoney A; St. James's University Hospital, Leeds, England., Lind P; Clinical Research Sörmland, Karolinska Institutet, Stockholm, Sweden., Glimelius B; Clinical Research Sörmland, University of Uppsala, Uppsala, Sweden., Falk S; Bristol Haematology and Oncology Centre, Bristol, England., Izbicki JR; University of Hamburg Medical Institutions UKE, Hamburg, Germany., Middleton GW; Royal Surrey County Hospital, Guildford, England., Cummins S; Royal Surrey County Hospital, Guildford, England., Ross PJ; Guy's Hospital, London, England., Wasan H; Hammersmith Hospital, London, England., McDonald A; The Beatson West of Scotland Cancer Centre, Glasgow, Scotland., Crosby T; Velindre Hospital, Cardiff, Wales., Ting Y; Queen Elizabeth Hospital, Birmingham, England., Patel K; Churchill Hospital, Oxford, England., Sherriff D; Derriford Hospital, Plymouth, England., Soomal R; Jersey General Hospital, Jersey, England., Borg D; Skåne University Hospital, Lund, Sweden., Sothi S; University Hospital Coventry, Coventry, England., Hammel P; Hôpital Beaujon, Clichy, France., Lerch MM; Greifswald University, Medicine, Greifswald, Germany., Mayerle J; Greifswald University, Medicine, Greifswald, Germany.; University Hospital Munich, Ludwig-Maximilians-University Munich, Germany., Tjaden C; University of Heidelberg, Heidelberg, Germany., Strobel O; University of Heidelberg, Heidelberg, Germany., Hackert T; University of Heidelberg, Heidelberg, Germany., Büchler MW; University of Heidelberg, Heidelberg, Germany., Neoptolemos JP; University of Heidelberg, Heidelberg, Germany.

مؤلفون مشاركون: European Study Group for Pancreatic Cancer

المصدر: JAMA surgery [JAMA Surg] 2019 Nov 01; Vol. 154 (11), pp. 1038-1048.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589553 Publication Model: Print Cited Medium: Internet ISSN: 2168-6262 (Electronic) Linking ISSN: 21686254 NLM ISO Abbreviation: JAMA Surg Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Pancreatic Ductal/*surgery , Neoplasm Recurrence, Local/*etiology , Pancreatic Neoplasms/*surgery, Adult ; Aged ; Aged, 80 and over ; Capecitabine/administration & dosage ; Carcinoma, Pancreatic Ductal/drug therapy ; Carcinoma, Pancreatic Ductal/mortality ; Chemotherapy, Adjuvant ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/mortality ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/mortality ; Prospective Studies ; Treatment Outcome ; Gemcitabine